Epithelial NLRP3 drives silica-induced lung injury and fibrosis through IL-18 and pro-fibrotic neutrophil recruitment
Authors:
Open Access
- 3 May 2026
- journal article
- research article
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 23 (1)
Abstract
Background: Silicosis is a progressive inflammatory and fibrotic lung disease with no effective treatments beyond symptom management. While global NLRP3 inflammasome deficiency attenuates silica-induced pathology, myeloid-specific Nlrp3 deletion provides no protection, suggesting that other cellular sources drive disease. Given that epithelial cells directly encounter inhaled silica particles and express NLRP3, we investigated the functional contribution of epithelial Nlrp3 to silicosis pathogenesis. Results: Using inducible epithelial-specific knockout models, we found that alveolar epithelial ( Sftpc + ) cells drive early caspase-1 activation and airway IL-18 production, while partially reducing tissue IL-1β maturation. Loss of alveolar epithelial Nlrp3 limited recruitment of pro-fibrotic Siglec-F + neutrophils, which expressed elevated fibrogenic mediators, and reduced airway neutrophil elastase levels. At day 14, Nlrp3 deficiency reduced persistent Siglec-F + neutrophils and broadly reduced airway inflammatory cytokines, accompanied by decreased lung damage, alveolitis, collagen deposition, fibrotic nodule expansion, and α-SMA expression, independent of detectable TGFβ changes. By day 28, during the chronic fibrotic phase, alveolar epithelial Nlrp3 deficiency continued to confer protection, reducing persistent inflammation, collagen accumulation, and fibrotic nodule size. In parallel, deletion of Nlrp3 in Scgb1a1 ⁺ bronchiolar epithelial cells reduced early inflammasome activation at day 3 and similarly decreased chronic lung inflammation, collagen deposition, and fibrotic nodule expansion, without affecting nodule number or cellularity at day 28. Conclusions: These findings establish epithelial Nlrp3 as a critical driver of silica-induced fibrotic remodeling through IL-18 and pro-fibrotic neutrophil recruitment, independent of canonical TGFβ mechanisms. This epithelial-centric paradigm provides a rationale for precision therapeutic strategies targeting epithelial NLRP3.Keywords
Funding Information
- Medical Research Future Fund (MRF2006197)
This publication has 43 references indexed in Scilit:
- Short-course intranasal LAT9997 therapy limits post-influenza bacterial pneumonia by recalibrating lung immunityMucosal Immunology, 2026
- Nociceptor neurons suppress alveolar macrophage-induced Siglec-F+ neutrophil-mediated inflammation to protect against pulmonary fibrosisImmunity, 2025
- Preclinical Mouse Model of Silicosis2023
- NLRP3 inflammasome activation in alveolar epithelial cells promotes myofibroblast differentiation of lung-resident mesenchymal stem cells during pulmonary fibrogenesisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
- Tumor-Promoting Ly-6G+ SiglecFhigh Cells Are Mature and Long-Lived NeutrophilsCell Reports, 2020
- Interleukin-22 Induces Interleukin-18 Expression from Epithelial Cells during Intestinal InfectionImmunity, 2015
- Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 miceArchives of Toxicology, 2013
- SilicosisThe Lancet, 2012
- The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, EpitheliumCell Stem Cell, 2009
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008